nsv511021
- Organism: Homo sapiens
- Study:nstd49 (Teague et al. 2010)
- Variant Type:complex substitution
- Method Type:Optical mapping
- Submitted on:NCBI35 (hg17)
- Variant Calls:2
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:37,805
- Publication(s):Teague et al. 2010
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 235 SVs from 62 studies. See in: genome view
Overlapping variant regions from other studies: 235 SVs from 62 studies. See in: genome view
Overlapping variant regions from other studies: 9 SVs from 6 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Outer Start | Outer Stop |
|---|---|---|---|---|---|---|---|---|---|
| nsv511021 | Remapped | Good | GRCh38.p12 | Primary Assembly | First Pass | NC_000012.12 | Chr12 | 80,438,403 | 80,476,207 |
| nsv511021 | Remapped | Perfect | GRCh37.p13 | Primary Assembly | First Pass | NC_000012.11 | Chr12 | 80,832,183 | 80,869,986 |
| nsv511021 | Submitted genomic | NCBI35 (hg17) | Primary Assembly | NC_000012.9 | Chr12 | 79,334,651 | 79,372,454 |
Variant Call Information
| Variant Call ID | Type | Sample ID | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | Other Calls in this Sample and Study |
|---|---|---|---|---|---|---|---|---|
| nssv618615 | complex substitution | CHM | Optical mapping | Optical mapping | Hydatidiform Mole | not provided | Submitter | 1,350 |
| nssv621618 | complex substitution | GM15510 | Optical mapping | Optical mapping | 1,740 |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | Assembly | Reciprocity | Sequence ID | Chr | Outer Start | Outer Stop |
|---|---|---|---|---|---|---|---|---|
| nssv618615 | Remapped | Good | GRCh38.p12 | First Pass | NC_000012.12 | Chr12 | 80,438,403 | 80,476,207 |
| nssv621618 | Remapped | Good | GRCh38.p12 | First Pass | NC_000012.12 | Chr12 | 80,445,110 | 80,476,207 |
| nssv618615 | Remapped | Perfect | GRCh37.p13 | First Pass | NC_000012.11 | Chr12 | 80,832,183 | 80,869,986 |
| nssv621618 | Remapped | Perfect | GRCh37.p13 | First Pass | NC_000012.11 | Chr12 | 80,838,890 | 80,869,986 |
| nssv618615 | Submitted genomic | NCBI35 (hg17) | NC_000012.9 | Chr12 | 79,334,651 | 79,372,454 | ||
| nssv621618 | Submitted genomic | NCBI35 (hg17) | NC_000012.9 | Chr12 | 79,341,358 | 79,372,454 |
No validation data were submitted for this variant
Clinical Assertions
| Variant Call ID | Sample ID | Type | Subject Phenotype | Clinical Interpretation | Source of Interpretation | Gender | Other Calls in this Sample and Study |
|---|---|---|---|---|---|---|---|
| nssv618615 | CHM | complex substitution | Hydatidiform Mole | not provided | Submitter | Female | 1,350 |